Controlling the cost of branded health service medicines
The government is proposing updates to the statutory scheme, which is one of two schemes that control the prices of branded medicines to the NHS. The changes may be alongside a successor voluntary scheme or as a standalone scheme. The consultation sets out proposed amendments in three main areas: increasing the allowed growth rate, revising which sales of branded medicines are exempt from scheme payments; and a new approach to control spending on older branded medicines. Click here to find out more.